Form 4: Alkermes Director Daglio Acquires Shares and Options in Recent Transaction

Director David Angelo Daglio Jr. reports acquisition of Alkermes plc shares and options, signaling potential confidence in the company's future.

Summary

• On May 31, 2024, David Angelo Daglio Jr., a director of Alkermes plc, acquired 8,013 restricted stock units and 17,492 non-qualified stock options.
• The restricted stock units vest in full on May 31, 2025, each representing a contingent right to receive one ordinary share.
• The stock options also vest and become exercisable in full on May 31, 2025, with an exercise price of $23.4.
• Following the reported transaction, Daglio directly owns 8,013 restricted stock units and 17,492 non-qualified stock options.
• A power of attorney was executed on February 5, 2024, granting certain individuals the authority to act on behalf of Emily Peterson Alva in matters related to SEC filings for Alkermes plc.

Sentiment

Score: 7

Explanation: Director's purchase of shares and options is generally a positive sign, suggesting confidence in the company's future performance. However, it's a single transaction and needs to be considered in the context of overall company performance and market conditions.

Positives

• A director's acquisition of shares and options can be seen as a positive signal, indicating confidence in the company's prospects.
• The vesting period of the restricted stock units and stock options aligns the director's interests with the long-term performance of the company.

Industry Context

Insider transactions are closely monitored as they can provide insights into a company's prospects. Director's purchases are generally viewed more favorably than sales.

Comparison to Industry Standards

• Comparing Alkermes' insider transaction activity to similar pharmaceutical companies like Biogen or Vertex Pharmaceuticals could provide context.
• Benchmarking the vesting schedules of the restricted stock units and stock options against industry norms for executive compensation packages would be useful.
• Analyzing the size of the director's holdings relative to their overall compensation and ownership stake in Alkermes can offer further insights.

Stakeholder Impact

• Shareholders may view the director's purchase as a positive signal.
• Employees may see it as a sign of confidence in the company's leadership and future.

Key Dates